Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of ROBO2 mRNA | increases expression | 18648102
|
C041524 |
aluminum sulfate |
aluminum sulfate results in decreased expression of ROBO2 mRNA | decreases expression | 15961160
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ROBO2 mRNA | decreases expression | 20382639
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ROBO2 mRNA | affects cotreatment|decreases expression | 18606552
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ROBO2 mRNA | affects cotreatment|decreases expression | 18606552
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ROBO2 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ROBO2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.88 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.21 | 19490988 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.90 | 3712494 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.68 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.79 | 17497229 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18270976 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17157402 18558336 19460635 19232924 17688650 20603192 18940202 18316065 18396377 18775368 16609825 18177632 18985861 15238991 17507914 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.46 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.20 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.57 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
1.77 | 3581430 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.78 | 7296757 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.88 | 10591146 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
7.26 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.26 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.79 | 20734317 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.35 | 9022650 19486331 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
3.15 | 11298694 8156756 14531868 18759878 8970840 2524372 11906362 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.79 | 2952479 3621924 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
4.15 | 18289764 9328219 11289319 6679447 6482804 7440962 18692083 8291058 9022650 9653073 1440618 18648102 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.15 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
5.05 | 7515130 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.35 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.51 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.36 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.06 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.84 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.66 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.46 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.58 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.58 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.41 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
9.41 | 18299183 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.33 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.46 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.46 | 6705139 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.34 | 7505956 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.84 | 6705139 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.46 | 17457083 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.30 | 15034207 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.98 | 16612254 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.46 | 8074119 9022650 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.20 | 6582329 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.35 | 15034207 9327722 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.69 | 1399818 3712494 598648 6587162 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.70 | 17228818 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.83 | 9205081 17941976 11980663 9488045 8764131 8840982 18798262 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.38 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.30 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.56 | 3581430 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
5.46 | 9205081 9488045 8764131 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.71 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.82 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.82 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.68 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.46 | 3988306 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.84 | 7296757 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
12.05 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
12.05 | 18606552 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.91 | 6228378 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.23 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.98 | 12752131 11422049 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.58 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.48 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.91 | 16876388 11738929 14763951 15475178 11044598 1511512 3137016 17978042 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.99 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.98 | 12833885 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.09 | 6582329 6587162 3712494 1399818 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.68 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.92 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.36 | 8074119 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.00 | 8888407 |
MESH:D014718 |
Vesico-Ureteral Reflux |
marker/mechanism |
|
| |